{"id":16357,"date":"2021-01-01T09:15:13","date_gmt":"2021-01-01T08:15:13","guid":{"rendered":"https:\/\/genomik-tuebingen.de\/?p=16357"},"modified":"2025-03-10T08:32:19","modified_gmt":"2025-03-10T07:32:19","slug":"new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia","status":"publish","type":"post","link":"https:\/\/cegat.com\/de\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/","title":{"rendered":"New Nonsense Variant c.2983G>T; p.Glu995* in the CACNA1A Gene Causes Progressive Autosomal Dominant Ataxia."},"content":{"rendered":"<p><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1\" style=\"--awb-font-size:24px;\"><p style=\"text-align: justify;\">Yannic Saathoff <sup>1<\/sup>, Saskia Biskup <sup>2 3<\/sup>, Claudia Funke <sup>3<\/sup>, Christian Roth <sup>1 4<\/sup><\/p>\n<\/div><\/div><\/div><\/div><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:60px;--awb-padding-bottom:60px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-1 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-text-color:var(--awb-custom_color_1);--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;text-transform:none;--fontSize:36;line-height:var(--awb-typography1-line-height);\">Abstract<\/h2><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-2\"><p style=\"text-align: justify;\">The genetic testing of hereditary ataxias includes screening for CAG-repeat expansions as well as pathogenic variants and nontranslated oligonucleotide expansion, which can cause spinocerebellar ataxia (SCA). Genotype-phenotype correlations of several SCA subtypes are difficult to establish, and the underlying mechanisms remain unclear. Here, we report a 58-year-old male patient who presented with severe generalized ataxia, horizontal gaze-evoked nystagmus, cognitive impairment and a positive family history of gait difficulties. Genetic panel diagnostics revealed a new nonsense pathogenic variant in the CACNA1A gene (c.2983G&gt;T; p. Glu995*) that segregated with the phenotype in three clinically affected family members. This gene is related to SCA type 6 (SCA6), episodic ataxia type 2, familial hemiplegic migraine type 1, among others. When it is supported by the clinical findings and family history, additional DNA sequencing beyond fragment length analysis should be performed.<\/p>\n<p style=\"text-align: left;\"><strong>Keywords<\/strong>: CACNA1A; Channelopathies; Spinocerebellar ataxia type 6.<\/p>\n<\/div><\/div><\/div><\/div><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-3 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--link_hover_color: var(--awb-color6);--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:60px;--awb-padding-bottom:60px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-tabs fusion-tabs-1 classic vertical-tabs icon-position-left mobile-mode-carousel\" style=\"--awb-title-border-radius-top-left:0px;--awb-title-border-radius-top-right:0px;--awb-title-border-radius-bottom-right:0px;--awb-title-border-radius-bottom-left:0px;--awb-title-padding-top:10px;--awb-title-padding-right:50px;--awb-title-padding-bottom:10px;--awb-title-padding-left:50px;--awb-alignment:start;--awb-inactive-color:var(--awb-custom_color_1);--awb-title-text-color:var(--awb-color5);--awb-title-active-text-color:var(--awb-custom_color_1);--awb-background-color:var(--awb-color5);--awb-border-color:rgba(0,0,0,0.06);--awb-active-border-color:var(--awb-color6);\"><div class=\"nav\"><ul class=\"nav-tabs\" role=\"tablist\" aria-orientation=\"vertical\"><li class=\"active\" role=\"presentation\"><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-cc7332bd55d850cb938\" aria-selected=\"true\" tabindex=\"0\" id=\"fusion-tab-cc7332bd55d850cb938\" href=\"#tab-cc7332bd55d850cb938\"><h3 class=\"fusion-tab-heading\">Referenzen<\/h3><\/a><\/li><li  role=\"presentation\"><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-7dc0f5a134964365719\" aria-selected=\"false\" tabindex=\"-1\" id=\"fusion-tab-7dc0f5a134964365719\" href=\"#tab-7dc0f5a134964365719\"><h3 class=\"fusion-tab-heading\">Autorinnen\/Autoren<\/h3><\/a><\/li><\/ul><\/div><div class=\"tab-content\"><div class=\"tab-pane fade fusion-clearfix in active\" role=\"tabpanel\" tabindex=\"0\" aria-labelledby=\"fusion-tab-cc7332bd55d850cb938\" id=\"tab-cc7332bd55d850cb938\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33121221\/\" target=\"_blank\" rel=\"noopener\">Ver\u00f6ffentlichung auf NCBI anschauen<\/a><\/p>\n<p><a href=\"\/de\/diagnostik\/seltene-erkrankungen\/epilepsie-und-hirnentwicklungsstoerungen\/\" target=\"_blank\" rel=\"noopener\"><span class=\"avia_iconbox_title\">zu unserem Panel f\u00fcr Epilepsie und Hirnentwicklungsst\u00f6rungen<\/span><\/a><\/div><div class=\"tab-pane fade fusion-clearfix\" role=\"tabpanel\" tabindex=\"0\" aria-labelledby=\"fusion-tab-7dc0f5a134964365719\" id=\"tab-7dc0f5a134964365719\">\n<ol>\n<li>Department of Neurology and Neurophysiology, DRK-Kliniken Nordhessen, Kassel, Germany.<\/li>\n<li>Center for Genomics and Transcriptomics (CeGaT) GmbH, Tuebingen, Germany.<\/li>\n<li>Practice for Human Genetics, Tuebingen, Germany.<\/li>\n<li>Department of Neurology, University of Marburg, Marburg, Germany.<\/li>\n<\/ol>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":18,"featured_media":54928,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[53],"tags":[244],"class_list":["post-16357","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-veroeffentlichungen","tag-epilepsie-und-hirnentwicklungsstoerungen"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>New Nonsense Variant c.2983G&gt;T; p.Glu995* in the CACNA1A Gene Causes Progressive Autosomal Dominant Ataxia.<\/title>\n<meta name=\"description\" content=\"Diese sowie noch weitere Publikationen in dem Bereich Panel-Diagnostik, an denen wir mitgewirkt haben, k\u00f6nnen Sie auf unserer Website finden.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Nonsense Variant c.2983G&gt;T; p.Glu995* in the CACNA1A Gene Causes Progressive Autosomal Dominant Ataxia.\" \/>\n<meta property=\"og:description\" content=\"Diese sowie noch weitere Publikationen in dem Bereich Panel-Diagnostik, an denen wir mitgewirkt haben, k\u00f6nnen Sie auf unserer Website finden.\" \/>\n<meta property=\"og:url\" content=\"\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/\" \/>\n<meta property=\"og:site_name\" content=\"CeGaT GmbH\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CeGaT.GmbH\/?locale=de_DE\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-01T08:15:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-10T07:32:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cegat.com\/wp-content\/uploads\/2022\/11\/CeGaT_KV_Neuigkeiten_Veroeffentlichungen.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1500\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Team CeGaT\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cegat.com\/de\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/\"},\"author\":{\"name\":\"Team CeGaT\",\"@id\":\"https:\/\/cegat.com\/de\/#\/schema\/person\/e3657a2842bf61167c8ef2011a85a777\"},\"headline\":\"New Nonsense Variant c.2983G>T; p.Glu995* in the CACNA1A Gene Causes Progressive Autosomal Dominant Ataxia.\",\"datePublished\":\"2021-01-01T08:15:13+00:00\",\"dateModified\":\"2025-03-10T07:32:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cegat.com\/de\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/\"},\"wordCount\":2325,\"image\":{\"@id\":\"\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cegat.com\/wp-content\/uploads\/2022\/11\/CeGaT_KV_Neuigkeiten_Veroeffentlichungen.jpg\",\"keywords\":[\"Epilepsie und Hirnentwicklungsst\u00f6rungen\"],\"articleSection\":[\"Ver\u00f6ffentlichungen\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cegat.com\/de\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/\",\"url\":\"\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/\",\"name\":\"New Nonsense Variant c.2983G>T; p.Glu995* in the CACNA1A Gene Causes Progressive Autosomal Dominant Ataxia.\",\"isPartOf\":{\"@id\":\"https:\/\/cegat.com\/de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/#primaryimage\"},\"image\":{\"@id\":\"\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cegat.com\/wp-content\/uploads\/2022\/11\/CeGaT_KV_Neuigkeiten_Veroeffentlichungen.jpg\",\"datePublished\":\"2021-01-01T08:15:13+00:00\",\"dateModified\":\"2025-03-10T07:32:19+00:00\",\"author\":{\"@id\":\"https:\/\/cegat.com\/de\/#\/schema\/person\/e3657a2842bf61167c8ef2011a85a777\"},\"description\":\"Diese sowie noch weitere Publikationen in dem Bereich Panel-Diagnostik, an denen wir mitgewirkt haben, k\u00f6nnen Sie auf unserer Website finden.\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/#primaryimage\",\"url\":\"https:\/\/cegat.com\/wp-content\/uploads\/2022\/11\/CeGaT_KV_Neuigkeiten_Veroeffentlichungen.jpg\",\"contentUrl\":\"https:\/\/cegat.com\/wp-content\/uploads\/2022\/11\/CeGaT_KV_Neuigkeiten_Veroeffentlichungen.jpg\",\"width\":1500,\"height\":800,\"caption\":\"Keyvisual zu Neuigkeiten und Ver\u00f6ffentlichungen\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cegat.com\/de\/#website\",\"url\":\"https:\/\/cegat.com\/de\/\",\"name\":\"CeGaT GmbH\",\"description\":\"Genetic Insights You Can Trust\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cegat.com\/de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cegat.com\/de\/#\/schema\/person\/e3657a2842bf61167c8ef2011a85a777\",\"name\":\"Team CeGaT\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New Nonsense Variant c.2983G>T; p.Glu995* in the CACNA1A Gene Causes Progressive Autosomal Dominant Ataxia.","description":"Diese sowie noch weitere Publikationen in dem Bereich Panel-Diagnostik, an denen wir mitgewirkt haben, k\u00f6nnen Sie auf unserer Website finden.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/","og_locale":"de_DE","og_type":"article","og_title":"New Nonsense Variant c.2983G>T; p.Glu995* in the CACNA1A Gene Causes Progressive Autosomal Dominant Ataxia.","og_description":"Diese sowie noch weitere Publikationen in dem Bereich Panel-Diagnostik, an denen wir mitgewirkt haben, k\u00f6nnen Sie auf unserer Website finden.","og_url":"\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/","og_site_name":"CeGaT GmbH","article_publisher":"https:\/\/www.facebook.com\/CeGaT.GmbH\/?locale=de_DE","article_published_time":"2021-01-01T08:15:13+00:00","article_modified_time":"2025-03-10T07:32:19+00:00","og_image":[{"width":1500,"height":800,"url":"https:\/\/cegat.com\/wp-content\/uploads\/2022\/11\/CeGaT_KV_Neuigkeiten_Veroeffentlichungen.jpg","type":"image\/jpeg"}],"author":"Team CeGaT","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/#article","isPartOf":{"@id":"https:\/\/cegat.com\/de\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/"},"author":{"name":"Team CeGaT","@id":"https:\/\/cegat.com\/de\/#\/schema\/person\/e3657a2842bf61167c8ef2011a85a777"},"headline":"New Nonsense Variant c.2983G>T; p.Glu995* in the CACNA1A Gene Causes Progressive Autosomal Dominant Ataxia.","datePublished":"2021-01-01T08:15:13+00:00","dateModified":"2025-03-10T07:32:19+00:00","mainEntityOfPage":{"@id":"https:\/\/cegat.com\/de\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/"},"wordCount":2325,"image":{"@id":"\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/#primaryimage"},"thumbnailUrl":"https:\/\/cegat.com\/wp-content\/uploads\/2022\/11\/CeGaT_KV_Neuigkeiten_Veroeffentlichungen.jpg","keywords":["Epilepsie und Hirnentwicklungsst\u00f6rungen"],"articleSection":["Ver\u00f6ffentlichungen"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/cegat.com\/de\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/","url":"\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/","name":"New Nonsense Variant c.2983G>T; p.Glu995* in the CACNA1A Gene Causes Progressive Autosomal Dominant Ataxia.","isPartOf":{"@id":"https:\/\/cegat.com\/de\/#website"},"primaryImageOfPage":{"@id":"\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/#primaryimage"},"image":{"@id":"\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/#primaryimage"},"thumbnailUrl":"https:\/\/cegat.com\/wp-content\/uploads\/2022\/11\/CeGaT_KV_Neuigkeiten_Veroeffentlichungen.jpg","datePublished":"2021-01-01T08:15:13+00:00","dateModified":"2025-03-10T07:32:19+00:00","author":{"@id":"https:\/\/cegat.com\/de\/#\/schema\/person\/e3657a2842bf61167c8ef2011a85a777"},"description":"Diese sowie noch weitere Publikationen in dem Bereich Panel-Diagnostik, an denen wir mitgewirkt haben, k\u00f6nnen Sie auf unserer Website finden.","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"\/new-nonsense-variant-c-2983gt-p-glu995-in-the-cacna1a-gene-causes-progressive-autosomal-dominant-ataxia\/#primaryimage","url":"https:\/\/cegat.com\/wp-content\/uploads\/2022\/11\/CeGaT_KV_Neuigkeiten_Veroeffentlichungen.jpg","contentUrl":"https:\/\/cegat.com\/wp-content\/uploads\/2022\/11\/CeGaT_KV_Neuigkeiten_Veroeffentlichungen.jpg","width":1500,"height":800,"caption":"Keyvisual zu Neuigkeiten und Ver\u00f6ffentlichungen"},{"@type":"WebSite","@id":"https:\/\/cegat.com\/de\/#website","url":"https:\/\/cegat.com\/de\/","name":"CeGaT GmbH","description":"Genetic Insights You Can Trust","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cegat.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/cegat.com\/de\/#\/schema\/person\/e3657a2842bf61167c8ef2011a85a777","name":"Team CeGaT"}]}},"_links":{"self":[{"href":"https:\/\/cegat.com\/de\/wp-json\/wp\/v2\/posts\/16357","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cegat.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cegat.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cegat.com\/de\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/cegat.com\/de\/wp-json\/wp\/v2\/comments?post=16357"}],"version-history":[{"count":0,"href":"https:\/\/cegat.com\/de\/wp-json\/wp\/v2\/posts\/16357\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cegat.com\/de\/wp-json\/wp\/v2\/media\/54928"}],"wp:attachment":[{"href":"https:\/\/cegat.com\/de\/wp-json\/wp\/v2\/media?parent=16357"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cegat.com\/de\/wp-json\/wp\/v2\/categories?post=16357"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cegat.com\/de\/wp-json\/wp\/v2\/tags?post=16357"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}